BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20152182)

  • 1. CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain.
    Wang J; Weaver IC; Gauthier-Fisher A; Wang H; He L; Yeomans J; Wondisford F; Kaplan DR; Miller FD
    Dev Cell; 2010 Jan; 18(1):114-25. PubMed ID: 20152182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
    Korzus E
    Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.
    Schoof M; Launspach M; Holdhof D; Nguyen L; Engel V; Filser S; Peters F; Immenschuh J; Hellwig M; Niesen J; Mall V; Ertl-Wagner B; Hagel C; Spohn M; Lutz B; Sedlacik J; Indenbirken D; Merk DJ; Schüller U
    Acta Neuropathol Commun; 2019 Dec; 7(1):199. PubMed ID: 31806049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the CH1 Domain in the Histone Acetyltransferase CREBBP Results in Autism-Relevant Behaviors in Mice.
    Zheng F; Kasper LH; Bedford DC; Lerach S; Teubner BJ; Brindle PK
    PLoS One; 2016; 11(1):e0146366. PubMed ID: 26730956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.
    Alarcón JM; Malleret G; Touzani K; Vronskaya S; Ishii S; Kandel ER; Barco A
    Neuron; 2004 Jun; 42(6):947-59. PubMed ID: 15207239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of CBP in forebrain principal neurons causes modest memory and transcriptional defects and a dramatic reduction of histone acetylation but does not affect cell viability.
    Valor LM; Pulopulos MM; Jimenez-Minchan M; Olivares R; Lutz B; Barco A
    J Neurosci; 2011 Feb; 31(5):1652-63. PubMed ID: 21289174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome.
    Lopez-Atalaya JP; Gervasini C; Mottadelli F; Spena S; Piccione M; Scarano G; Selicorni A; Barco A; Larizza L
    J Med Genet; 2012 Jan; 49(1):66-74. PubMed ID: 21984751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms of Rubinstein-Taybi syndrome.
    Park E; Kim Y; Ryu H; Kowall NW; Lee J; Ryu H
    Neuromolecular Med; 2014 Mar; 16(1):16-24. PubMed ID: 24381114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBP regulates the differentiation of interneurons from ventral forebrain neural precursors during murine development.
    Tsui D; Voronova A; Gallagher D; Kaplan DR; Miller FD; Wang J
    Dev Biol; 2014 Jan; 385(2):230-41. PubMed ID: 24247009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.
    Lopez-Atalaya JP; Ciccarelli A; Viosca J; Valor LM; Jimenez-Minchan M; Canals S; Giustetto M; Barco A
    EMBO J; 2011 Aug; 30(20):4287-98. PubMed ID: 21847097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.
    Murata T; Kurokawa R; Krones A; Tatsumi K; Ishii M; Taki T; Masuno M; Ohashi H; Yanagisawa M; Rosenfeld MG; Glass CK; Hayashi Y
    Hum Mol Genet; 2001 May; 10(10):1071-6. PubMed ID: 11331617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.
    Viosca J; Lopez-Atalaya JP; Olivares R; Eckner R; Barco A
    Neurobiol Dis; 2010 Jan; 37(1):186-94. PubMed ID: 19822209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To learn better, keep the HAT on.
    Martin KC; Sun YE
    Neuron; 2004 Jun; 42(6):879-81. PubMed ID: 15207231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.
    Shim JH; Greenblatt MB; Singh A; Brady N; Hu D; Drapp R; Ogawa W; Kasuga M; Noda T; Yang SH; Lee SK; Rebel VI; Glimcher LH
    J Clin Invest; 2012 Jan; 122(1):91-106. PubMed ID: 22133875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction.
    Hallam TM; Bourtchouladze R
    Cell Mol Life Sci; 2006 Aug; 63(15):1725-35. PubMed ID: 16786226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of melatonin on neuronal differentiation requires CBP/p300-mediated acetylation of histone H3 lysine 14.
    Li X; Chen X; Zhou W; Ji S; Li X; Li G; Liu G; Wang F; Hao A
    Neuroscience; 2017 Nov; 364():45-59. PubMed ID: 28782640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury.
    Yildirim F; Ji S; Kronenberg G; Barco A; Olivares R; Benito E; Dirnagl U; Gertz K; Endres M; Harms C; Meisel A
    PLoS One; 2014; 9(4):e95465. PubMed ID: 24748101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18.
    Liu Y; Xing ZB; Zhang JH; Fang Y
    FEBS Lett; 2013 Apr; 587(7):847-53. PubMed ID: 23434580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the histone chaperone ASF1 to the CBP bromodomain promotes histone acetylation.
    Das C; Roy S; Namjoshi S; Malarkey CS; Jones DN; Kutateladze TG; Churchill ME; Tyler JK
    Proc Natl Acad Sci U S A; 2014 Mar; 111(12):E1072-81. PubMed ID: 24616510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing.
    Tie F; Banerjee R; Stratton CA; Prasad-Sinha J; Stepanik V; Zlobin A; Diaz MO; Scacheri PC; Harte PJ
    Development; 2009 Sep; 136(18):3131-41. PubMed ID: 19700617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.